|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/12/18 Idt Corp 10-Q 1/31/18 69:4.3M Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 398K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 20K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 21K
12: R1 Document and Entity Information HTML 42K
13: R2 Consolidated Balance Sheets HTML 130K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 44K
15: R4 Consolidated Statements of Operations (Unaudited) HTML 86K
16: R5 Consolidated Statements of Comprehensive Income HTML 45K
(Loss) (Unaudited)
17: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 114K
18: R7 Consolidated Statements of Cash Flows HTML 23K
(Parenthetical) (Unaudited)
19: R8 Basis of Presentation HTML 26K
20: R9 IDT Financial Services Holding Limited Assets and HTML 50K
Liabilities Held for Sale
21: R10 Spin-Off of Rafael Holdings, Inc. and Investment HTML 41K
in Rafael Pharmaceuticals, Inc.
22: R11 Marketable Securities HTML 67K
23: R12 Fair Value Measurements HTML 59K
24: R13 Equity HTML 44K
25: R14 Earnings (Loss) Per Share HTML 45K
26: R15 Revolving Credit Facility HTML 24K
27: R16 Accumulated Other Comprehensive Loss HTML 32K
28: R17 Business Segment Information HTML 46K
29: R18 Commitments and Contingencies HTML 53K
30: R19 Other Income (Expense), Net HTML 32K
31: R20 Income Tax and New Jersey Corporation Business Tax HTML 39K
32: R21 Recently Issued Accounting Standard Not Yet HTML 40K
Adopted
33: R22 IDT Financial Services Holding Limited Assets and HTML 46K
Liabilities Held for Sale (Tables)
34: R23 Proposed Spin-Off of Rafael Holdings, Inc. and HTML 26K
Investment in Rafael Pharmaceuticals, Inc.
(Tables)
35: R24 Marketable Securities (Tables) HTML 66K
36: R25 Fair Value Measurements (Tables) HTML 48K
37: R26 Equity (Tables) HTML 31K
38: R27 Earnings (Loss) Per Share (Tables) HTML 43K
39: R28 Accumulated Other Comprehensive Loss (Tables) HTML 30K
40: R29 Business Segment Information (Tables) HTML 39K
41: R30 Other Income (Expense), Net (Tables) HTML 30K
42: R31 IDT Financial Services Holding Limited Assets and HTML 91K
Liabilities Held for Sale (Details)
43: R32 IDT Financial Services Holding Limited Assets and HTML 29K
Liabilities Held for Sale (Details 1)
44: R33 IDT Financial Services Holding Limited Assets and HTML 30K
Liabilities Held for Sale (Details Textual)
45: R34 Spin-Off of Rafael Holdings, Inc. and Investment HTML 29K
in Rafael Pharmaceuticals, Inc. (Details)
46: R35 Spin-Off of Rafael Holdings, Inc. and Investment HTML 87K
in Rafael Pharmaceuticals, Inc. (Details Textual)
47: R36 Marketable Securities (Details) HTML 69K
48: R37 Marketable Securities (Details 1) HTML 35K
49: R38 Marketable Securities (Details 2) HTML 44K
50: R39 Marketable Securities (Details 3) HTML 30K
51: R40 Marketable Securities (Details Textual) HTML 39K
52: R41 Fair Value Measurements (Details) HTML 38K
53: R42 Fair Value Measurements (Details 1) HTML 28K
54: R43 Fair Value Measurements (Details Textual) HTML 23K
55: R44 Equity (Details) HTML 62K
56: R45 Equity (Details Textual) HTML 64K
57: R46 Earnings (Loss) Per Share (Details) HTML 33K
58: R47 Earnings (Loss) Per Share (Details 1) HTML 28K
59: R48 Revolving Credit Facility (Details) HTML 41K
60: R49 Accumulated Other Comprehensive Loss (Details) HTML 49K
61: R50 Accumulated Other Comprehensive Loss (Details HTML 29K
Textual)
62: R51 Business Segment Information (Details) HTML 45K
63: R52 Business Segment Information (Details Textual) HTML 21K
64: R53 Commitments and Contingencies (Details) HTML 48K
65: R54 Other Income (Expense), Net (Details) HTML 35K
66: R55 Income Tax and New Jersey Corporation Business Tax HTML 47K
(Details)
68: XML IDEA XML File -- Filing Summary XML 123K
67: EXCEL IDEA Workbook of Financial Reports XLSX 71K
6: EX-101.INS XBRL Instance -- idt-20180131 XML 1.17M
8: EX-101.CAL XBRL Calculations -- idt-20180131_cal XML 144K
9: EX-101.DEF XBRL Definitions -- idt-20180131_def XML 523K
10: EX-101.LAB XBRL Labels -- idt-20180131_lab XML 1.10M
11: EX-101.PRE XBRL Presentations -- idt-20180131_pre XML 739K
7: EX-101.SCH XBRL Schema -- idt-20180131 XSD 145K
69: ZIP XBRL Zipped Folder -- 0001213900-18-002826-xbrl Zip 122K
EXHIBIT 32.2
Certification
Pursuant to
18 U.S.C. Section 1350
(as Adopted Pursuant to Section 906 of
the Sarbanes-Oxley Act Of 2002)
In connection with the Quarterly Report of IDT Corporation (the “Company”) on Form 10-Q for the quarter ended January 31, 2018 as filed with the Securities and Exchange Commission (the “Report”), I, Marcelo Fischer, Senior Vice President of Finance of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 12, 2018
| /s/ Marcelo Fischer | |
Marcelo Fischer Senior Vice President of Finance (Principal Financial Officer) |
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to IDT Corporation and will be retained by IDT Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/12/18 | SC 13G/A | ||
| For Period end: | 1/31/18 | |||
| List all Filings | ||||